A Multicenter, Open-Label, Three-Arm, Active-Controlled Study to Assess the Efficacy and Safety of the Oral Contraceptive SH T00186D in Two Flexible Extended Regimens and a Conventional Regimen of Yaz in 1756 Healthy Females for 1 Year.
Phase of Trial: Phase III
Latest Information Update: 07 May 2014
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Bayer
- 29 Jun 2012 Actual patient number changed from 1885 to 1887 as reported by ClinicalTrials.gov.
- 18 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Dec 2009 Actual end date (Nov 2009) and actual patient no (1885) added as reported by ClinicalTrials.gov.